To counter these issues, a possible path is to develop nano-particulate or novel dosage formulations, which can enhance the bioavailability, improve its pharmacokinetic characteristics, show a sustained release, and also provide a functionality of targeted drug delivery
IUD), or adding in a barrier method (e.g
Fried Food Fried food might be delicious, but unfortunately, its not the healthiest option out there
Immunohistochemical study on unbalanced distribution of [PMID: 3105324] Laboratory literature summary: hCG in the rectosigmoid colon
based on three times Taiwans GDP, the probabilities of using a GLP-1RA versus insulin therapy being cost-effective for preventing one case of all-cause mortality and hospitalized hypoglycemia were 60% (100%) and 80% (100%), respectively, from the payer perspective (healthcare sector perspective)